Bridging the major prospective national eye institute-sponsored glaucoma clinical trials and clinical practice

Journal of Glaucoma

Volumn 20, Issue 1, 2011, Pages 1-2

  De Moraes, Carlos Gustavo ^a,b   Ritch, Robert ^a,c   Liebmann, Jeffrey M ^a,b,d  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; EDITORIAL; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MEDICAL DECISION MAKING; MEDICAL ERROR; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VISUAL FIELD DEFECT;

CLINICAL TRIALS AS TOPIC; DECISION MAKING; EVIDENCE-BASED MEDICINE; GLAUCOMA; HUMANS; NATIONAL EYE INSTITUTE (U.S.); OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RESEARCH DESIGN; UNITED STATES;

EID: 78651428108     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181d1d234     Document Type: Editorial

References (21)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 701-713.
2. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268-1279.
3. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:490-491.
4. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
5. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol. 1995;120:718-731.
6. Cioffi GA, Liebmann JM. Translating the OHTS results into clinical practice. J Glaucoma. 2002;11:375-377.
7. Singh K. The randomized clinical trial: beware of limitations. J Glaucoma. 2004;13:87-89.
8. Jampel HD. We should treat fewer patients with elevated intraocular pressure now that we know the results of the ocular hypertension treatment study. Arch Ophthalmol. 2004;122:378-379.
9. Wishart PK. Interpretation of the glaucoma "andmark studies". Br J Ophthalmol. 2009;93:561-562.
10. Kass MA, Gordon MO, Kymes SM. Incorporating the results of the ocular hypertension treatment study into clinical practice. Arch Ophthalmol. 2005;123:1021-1022.
11. Conti CR. Clinical practice guides. Clin Cardiol. 2009;32:174-175.
12. Stanley K. Evaluation of randomized controlled trials. Circulation. 2007;115:1819-1822.
13. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297: 1233-1240.
14. Möller HJ. Do effectiveness (real world") studies on antipsychotics tell us the real truth? Eur Arch Psychiatry Clin Neurosci. 2008, 258: 257-270
15. Kent DM, Kitsios G. Against pragmatism: on efficacy, effectiveness and the real world. Trials. 2009;10:48.
16. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-1632.
17. Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005;43:551-557.
18. De Moraes CG, Prata TS, Tello C, et al. Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression. Arch Ophthalmol. 2009;127:1129-1134.
19. De Moraes CG, Prata TS, Liebmann CA, et al. Spatially consistent, localized visual field loss before and after disc hemorrhage. Invest Ophthalmol Vis Sci. 2009;50:4727-4733.
20. Teng CC, De Moraes CG, Prata TS, et al. Beta-zone parapapillary atrophy and the velocity of glaucoma progression. Ophthalmology. 2009. (in press).
21. Folgar FA, De Moraes CG, Teng CC, et al. Glaucoma surgery decreases the rate of localized and global visual field progression. Am J Ophthalmol. 2009. (in press).